-
11m 55sPart 3 | Session 11 SPIRIT-HCM: Quality of Life After SM in Obstructive Patients With HCM
-
16m 38sPart 1 | Session 1 AHA 2021 Late-breaker Discussion: The EMPULSE Trial
-
16m 2sPart 1 | Session 2 AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial
-
12m 12sPart 1 | Session 3 AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study
-
9m 51s
-
5m 28sPart 3 | Session 1 Population Strategies for the Management of Hypertension
-
5m 41sPart 3 | Session 2 ROSE: CETPi Lowers LDL-C in Patients Taking High Intensity Statins
-
7m 58s
-
6m 56sPart 3 | Session 4 EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns
-
6m 35sPart 3 | Session 5 EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp
-
10m 20s
-
4m 26sPart 3 | Session 7 SGLT2 is Associated with Reduction in Atrial-Arrythmic Events
-
8m 26sPart 3 | Session 8 SMART-CRT: Effects of AV Optimization on CRT Outcomes
-
10m 10s
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen provide a concise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021.
For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators.
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Faculty Biographies
Christiane Angermann
Professor
Prof Christiane E. Angermann is trained in Medicine/Cardiology in Munich. At the Munich Univ. Hospital, she established a Multidisciplinary Program for Advanced Heart Failure (HF)/HTX. In 2001, she became Professor of Medicine/Cardiology at Würzburg University, heading the Cardiology Division, Department of Medicine II. She is one of the 5 founders of the Comprehensive Heart Failure Center Würzburg (CHFC), became CHFC Director of Clinical Research in 2010, and is currently Senior CHFC Professor of Clinical Research in Cardiology/HF.
Her main interests are healthcare research, eHealth and telemedicine, multi-morbidity, heart-mind-body interactions and prevention of HF.
Prof Angermann is/was an EC/SC member and/or National Leader of multiple clinical trials, (e.g., REPORT-HF, MEMS-HF, PASSPORT-HF, EMPULSE), and acts as reviewer, Ed. Board member or Editor-in-Chief (Current Heart Failure Reports) for many journals.